Friess Associates’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-170,476	Closed	-$21M	–	114
2020 Q2	$21M	Sell	170,476 -85,319	-33%	-$10.5M	1.96%	9
2020 Q1	$21.6M	Buy	255,795 +209,095	+448%	+$17.7M	2.16%	11
2019 Q4	$3.95M	Buy	+46,700	New	+$3.95M	0.27%	86